000 | 01985 a2200529 4500 | ||
---|---|---|---|
005 | 20250516215824.0 | ||
264 | 0 | _c20140804 | |
008 | 201408s 0 0 eng d | ||
022 | _a1529-2401 | ||
024 | 7 |
_a10.1523/JNEUROSCI.5106-13.2014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHanson, Jesse E | |
245 | 0 | 0 |
_aChronic GluN2B antagonism disrupts behavior in wild-type mice without protecting against synapse loss or memory impairment in Alzheimer's disease mouse models. _h[electronic resource] |
260 |
_bThe Journal of neuroscience : the official journal of the Society for Neuroscience _cJun 2014 |
||
300 |
_a8277-88 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlzheimer Disease _xcomplications |
650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAttention Deficit and Disruptive Behavior Disorders _xchemically induced |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aMemory Disorders _xetiology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aSynapses _xpathology |
700 | 1 | _aMeilandt, William J | |
700 | 1 | _aGogineni, Alvin | |
700 | 1 | _aReynen, Paul | |
700 | 1 | _aHerrington, James | |
700 | 1 | _aWeimer, Robby M | |
700 | 1 | _aScearce-Levie, Kimberly | |
700 | 1 | _aZhou, Qiang | |
773 | 0 |
_tThe Journal of neuroscience : the official journal of the Society for Neuroscience _gvol. 34 _gno. 24 _gp. 8277-88 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1523/JNEUROSCI.5106-13.2014 _zAvailable from publisher's website |
999 |
_c23910699 _d23910699 |